作者
Thierry Conroy,Pascal Hammel,Mohamed Hebbar,Méher Ben Abdelghani,Alice C. Wei,Jean‐Luc Raoul,Laurence Choné,E. François,Pascal Artru,James J. Biagi,Thierry Lecomte,Eric Assénat,Roger Faroux,Marc Ychou,Julien Volet,Alain Sauvanet,Gilles Breysacher,Frédéric Di Fiore,C. Cripps,Petr Kavan,Patrick Texereau,Karine Bouhier‐Leporrier,Faiza Khemissa-Akouz,Jean-Louis Legoux,Béata Juzyna,Sophie Gourgou,Christopher J. O’Callaghan,Claire Jouffroy-Zeller,Patrick Rat,David Malka,Florence Castan,Jean‐Baptiste Bachet
摘要
Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall survival than gemcitabine therapy. We compared the efficacy and safety of a modified FOLFIRINOX regimen with gemcitabine as adjuvant therapy in patients with resected pancreatic cancer.
彭于彦祖
丰知然
毛豆
归尘
cocolu
鲤鱼鸽子
QDU
愤怒的乐松
杳鸢
坚强的广山
mhl11
子车茗
Billy
pluto
萧水白
tuanheqi
劲秉
模糊中正
一出生就是美钕
smash
皖公网安备34019202002308
